Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

760 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
ST-segment monitoring with continuous 12-lead ECG improves early risk stratification in patients with chest pain and ECG nondiagnostic of acute myocardial infarction.
Jernberg T, Lindahl B, Wallentin L. Jernberg T, et al. Among authors: wallentin l. J Am Coll Cardiol. 1999 Nov 1;34(5):1413-9. doi: 10.1016/s0735-1097(99)00370-8. J Am Coll Cardiol. 1999. PMID: 10551686
In a multivariate analysis, only troponin T > or = 0.10 microg/l and the presence of ST-episodes came out as independent predictors of cardiac death or MI. ...
In a multivariate analysis, only troponin T > or = 0.10 microg/l and the presence of ST-episodes came out as independent predictor …
Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease.
Oldgren J, Wallentin L, Grip L, Linder R, Nørgaard BL, Siegbahn A. Oldgren J, et al. Among authors: wallentin l. Eur Heart J. 2003 Jan;24(1):86-93. doi: 10.1016/s0195-668x(02)00312-3. Eur Heart J. 2003. PMID: 12559940 Clinical Trial.
Long-term management--the way forward?
Wallentin L. Wallentin L. Clin Cardiol. 2000 Jan;23 Suppl 1(Suppl ):I13-7. doi: 10.1002/clc.4960231305. Clin Cardiol. 2000. PMID: 10680039 Free PMC article. Review.
Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease. FRISC study group. Fragmin during Instability in Coronary Artery Disease.
Sätre H, Holmvang L, Wagner GS, Lindahl B, Wallentin L. Sätre H, et al. Among authors: wallentin l. Eur Heart J. 1999 May;20(9):645-52. doi: 10.1053/euhj.1998.1339. Eur Heart J. 1999. PMID: 10208784 Clinical Trial.
Management strategies for a better outcome in unstable coronary artery disease.
Campbell RW, Wallentin L, Verheugt FW, Turpie AG, Maseri A, Klein W, Cleland JG, Bode C, Becker R, Anderson J, Bertrand ME, Conti CR. Campbell RW, et al. Among authors: wallentin l. Clin Cardiol. 1998 May;21(5):314-22. doi: 10.1002/clc.4960210504. Clin Cardiol. 1998. PMID: 9595213 Free PMC article. Review.
Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease.
Toss H, Gnarpe J, Gnarpe H, Siegbahn A, Lindahl B, Wallentin L. Toss H, et al. Among authors: wallentin l. Eur Heart J. 1998 Apr;19(4):570-7. doi: 10.1053/euhj.1997.0771. Eur Heart J. 1998. PMID: 9597405
Safety and efficacy of abciximab combined with dalteparin in treatment of acute coronary syndromes.
James S, Armstrong P, Califf R, Husted S, Kontny F, Niemminen M, Pfisterer M, Simoons ML, Wallentin L. James S, et al. Among authors: wallentin l. Eur Heart J. 2002 Oct;23(19):1538-45. doi: 10.1053/euhj.2002.3257. Eur Heart J. 2002. PMID: 12242074 Clinical Trial.
Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment.
Jernberg T, Abrahamsson P, Lindahl B, Johanson P, Wallentin L, Dellborg M. Jernberg T, et al. Among authors: wallentin l. Eur Heart J. 2002 Jul;23(14):1093-101. doi: 10.1053/euhj.2001.3043. Eur Heart J. 2002. PMID: 12090747 Clinical Trial.
Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy.
Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Lindmark E, et al. Among authors: wallentin l. JAMA. 2001 Nov 7;286(17):2107-13. doi: 10.1001/jama.286.17.2107. JAMA. 2001. PMID: 11694151 Clinical Trial.
RESULTS: Plasma levels of IL-6 that were at least 5 ng/L compared with levels lower than 5 ng/L were associated with greatly increased mortality in the noninvasive group (7.9% vs 2.3%; relative risk [RR], 3.47; 95% confidence interval [CI], 1.94-6.21) and in the pla …
RESULTS: Plasma levels of IL-6 that were at least 5 ng/L compared with levels lower than 5 ng/L were associated with greatly i …
Comparison of continuous vectorcardiography and continuous 12-lead electrocardiography of patients with unstable coronary artery disease: do they identify the same population?
Jernberg T, Abrahamsson P, Lindahl B, Wallentin L, Dellborg M. Jernberg T, et al. Among authors: wallentin l. Coron Artery Dis. 2001 May;12(3):187-95. doi: 10.1097/00019501-200105000-00005. Coron Artery Dis. 2001. PMID: 11352075 Clinical Trial.
760 results
Jump to page
Feedback